Target Profile
```
Patient's age must be greater than or equal to 18 years.
Patient's gender must be female.
Patient must have active diagnosis of Human epidermal growth factor 2 negative carcinoma of breast.
Patient must have active diagnosis of Estrogen receptor negative neoplasm.
Patient must have active diagnosis of Progesterone receptor negative neoplasm.
Patient must have a health evaluation score of ECOG performance status grade:Prid:Pt:^Patient:Nom:Observed less than or equal to 1.
Patient must not be pregnant.
Patient must not have historical medication for the treatment of Breast Neoplasms.
Patient must not have historical medication with ingredient Carboplatin.
Patient must not have historical medication with ingredient Paclitaxel.
Patient must not have historical medication with ingredient Doxorubicin.
Patient must not have historical medication with ingredient Cyclophosphamide.
Patient must not have historical medication with mechanism of action PARP inhibitor.
Patient must not have historical diagnosis of Seizure within less than or equal to 12 months.
Patient must not have adverse event of Grade 2 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 3 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 4 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 5 Peripheral sensory neuropathy.
Patient must not have adverse event of Grade 2 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 3 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 4 Peripheral motor neuropathy.
Patient must not have adverse event of Grade 5 Peripheral motor neuropathy.
```